Ana I. Casanegra, M.D., M.S.

Speciality

1. Internist
2. Vascular Medicine Specialist

About

Dr. Casanegra is an Associate Professor of Medicine with a primary appointment in the Department of Cardiovascular Diseases (Vascular Division). She is the current Director of the Thrombosis, Anticoagulation and Thrombophilia Clinic and the co-Director of the multidisciplinary Antiphospholipid Syndrome Clinic. She has undergone extensive training prior to joining the Mayo Clinic Vascular Division. This includes fellowship completion in Vascular Medicine at Cleveland Clinic and a master's in clinical and Translational Research at the School of Public Health at the University of Oklahoma. Her research interests include antiphospholipid syndrome, venous thromboembolism prevention and treatment, and diagnostics of vascular diseases. Her clinical interests include antiphospholipid syndrome, peripheral artery disease, non-atherosclerotic arterial disease, aneurysms, arterial and venous thrombosis including complex thrombophilia evaluation and management, and anticoagulation management.

Conditions treated

1. Aneurysm

2. Antiphospholipid syndrome
3. Antithrombin deficiency
4. Aortic dissection
5. Arterial embolism
6. Carotid artery disease
7. Carotid artery dissection
8. Congenital blood clotting disorder
9. Deep vein thrombosis
10. Factor V Leiden
11. Fibromuscular dysplasia
12. Peripheral artery disease
13. Protein C deficiency
14. Protein S deficiency
15. Pulmonary embolism
16. Renal artery stenosis
17. Thrombophilia
18. Thrombophlebitis
19. Vasospastic disorders
20. Venous thrombosis
21. Visceral artery aneurysm

Procedures performed

1. Anticoagulant therapy

2. Ultrasound

Interests

• Antiphospholipid syndrome

• Vascular medicine

• Peripheral arterial disease
• Thromboembolic disease
• Deep vein thrombosis
• Pulmonary embolism
• Aneurysmal and dissection disease
• Carotid, vertebral, renal and mesenteric artery stenosis
• Vascular ultrasound and vascular physiologic studies

  Education

• 2015
  Master of Science - Clinical and Translational ResearchUniversity of Oklahoma College of Public Health
• 2010
  FellowCleveland Clinic Foundation
• 2009
  Chief ResidentBridgeport Hospital/Yale University Program
• 2008
  ResidencyDanbury Hospital/Yale University Program
• 2005
  FellowHospital Privado Universitario de Cordoba
• 2002
  Chief ResidentHospital Privado Universitario de Cordoba
• 2002
  ResidencyHospital Privado Universitario de Cordoba
• 1997
  MDFacultad de Ciencias Medicas, Universidad Nacional de Cordoba
• Show less education

  Activities and honors

  Certifications

• 2010
  Vascular MedicineAmerican Board of Vascular Medicine
• 2008
  Internal MedicineAmerican Board of Internal Medicine

• Awards and honors

• 2015

  Inducted to the Academy of Teaching ScholarsUniversity of Oklahoma Health Sciences Center
• 2014
  Oklahoma Shared Clinical and Translational Resources (OSCTR) ScholarUniversity of Oklahoma Health Sciences Center
• 2012
  Physician in Training Travel ScholarshipAmerican College of Phlebology
• 2010
  Most voted interactive caseSociety of Vascular Medicine website
• 2009
  PAD Workshop Scholarship for AttendanceAmerican Heart Association
• 2008
  Second prize for original research oral presentation. 23rd Annual JL Belsky, MD, Research DayDanbury Hospital/Yale University Program
• 2003
  Prof. Dr. Juan C Fasciolo ACE polymorphism and diastolic essential hypertensionNational Meeting of Arterial Hypertension
• 1995
  Second prize in short story contestAssociation of high school and Tertiary Education Teachers
• 1995
  First prize and publicationConcurso Literario de poesia y cuento Direccion de cultura de la Provincia de Cordoba
• 1993
  Goethe Institut und Deutscher Volkhochschul-verband ScholarshipGoethe Instiut Staufen
• 1989
  SemifinalistRioplatense Mathematical Olympiad
• 1988
  SemifinalistRioplatense Mathematical Olympiad
• 1987
  SemifinalistRioplatense Mathematical Olympiad
• Show fewer awards and honors

  Professional memberships

• 2022 - present

  International Society of Thrombosis and Haemostasis
• 2021 - 2023
  American Heart Association
• 2020 - present
  Alliance for Physician Certification and Advancement
• 2020 - present
  Alliance for Physician Certification & Advancement
• 2020 - 2022
  AskMayoExpert
• 2020 - present
  AskMayoExpert
• 2020 - present
  Society for Vascular Medicine
• 2020 - present
  American Heart Association
• 2020 - 2022
  Journal of Vascular Medicine
• 2020 - present
  Enterprise Anticoagulation Quality Committee
• 2019 - present
  AskMayoExpert, DVT/PE Multidisciplinary Knowledge Content Board
• 2019 - 2021
  Society for Vascular Medicine
• 2019 - 2021
  Society for Vascular Medicine
• 2019 - present
  Department of Cardiology, Outpatient Practice Subcommittee
• 2019 - 2021
  Society for Vascular Medicine
• 2018 - present
  Clinical Practice Committee, Gonda Vascular Center
• 2018 - 2022
  Epic Optimization Committee
• 2018 - present
  AskMayoExpert, Vascular Medicine
• 2018 - present
  Ask Mayo Expert
• 2017 - 2020
  Epic Superuser
• 2017 - 2022
  Society for Vascular Medicine
• 2017 - 2021
  Society for Vascular Medicine
• 2016 - 2021
  Society for Vascular Medicine
• 2016 - 2021
  Society for Vascular Medicine
• 2015 - present
  Society of Diagnostic Medical Sonography
• 2015 - present
  International Society on Thrombosis and Hemostasis
• 2014 - present
  American Heart Association
• 2013 - 2022
  Society for Vascular Medicine
• 2012 - 2016
  Clinical Competency Committee, University of Oklahoma Health Sciences Center
• 2012 - 2020
  American Board of Vascular Medicine
• 2011 - present
  American Registry for Diagnostic Medical Sonography
• 2009 - present
  Society for Vascular Medicine

Show fewer professional memberships

Publications

Print

1. Houghton DE, Wysokinski WE, Padrnos LJ, Shah S, Wysokinska E, Pruthi R, Ghorbanzadeh A, Ashrani A, Sridharan M, McBane RD, Padmanabhan A, Casanegra AI. Venous thromboembolism after COVID-19 vaccination in patients with thrombophilia. Am J Hematol. 2023 Apr; 98 (4):566-570 Epub 2023 Jan 28
   View PubMed
2. Kurmann R, El-Am E, Ahmad A, Abbasi MA, Mazur P, Akiki E, Anand V, Herrmann J, Casanegra A, Young P, Crestanello J, Bois MC, Maleszewski JJ, Klarich K. Cardiac Masses Discovered by Echocardiogram; What to Do Next? Structural Heart. 2023.
3. Wysokinska EM, Houghton DE, Vlazny DT, Ashrani AA, Froehling DA, Meverden R, Hodge DO, Peterson LG, McBane RD, Wysokinski WE, Casanegra AI. Incidental pulmonary embolism in cancer and noncancer patients: Prospective cohort study. Eur J Haematol. 2023 Jan; 110 (1):88-98 Epub 2022 Oct 21
   View PubMed
4. Wysokinski WE, Houghton DE, Vlazny DT, Ashrani AA, Froehling DA, Kamath PS, Meverden RA, Hodge DO, Peterson LG, Lang TR, McBane RD, Casanegra AI. Influence of primary cancer site on clinical outcomes of anticoagulation for associated venous thromboembolism. Thromb Res. 2023 Jan; 221:37-44 Epub 2022 Nov 15
   View PubMed
5. McBane Ii RD, Vlazny DT, Houghton D, Casanegra AI, Froehling D, Daniels P, Riaz IB, Hodge DO, Wysokinski WE. Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment. Thromb Haemost. 2022 Dec 27 [Epub ahead of print]
   View PubMed
6. McBane RD 2nd, Murphree DH, Liedl D, Lopez-Jimenez F, Attia IZ, Arruda-Olson A, Scott CG, Prodduturi N, Nowakowski SE, Rooke TW, Casanegra AI, Wysokinski WE, Swanson KE, Houghton DE, Bjarnason H, Wennberg PW. Artificial intelligence for the evaluation of peripheral artery disease using arterial Doppler waveforms to predict abnormal ankle-brachial index. Vasc Med. 2022 Aug; 27 (4):333-342 Epub 2022 May 10
   View PubMed
7. Houghton DE, Wysokinski W, Casanegra AI, Padrnos LJ, Shah S, Wysokinska E, Pruthi R, Ashrani A, Sridharan M, Baumann-Kreuziger L, McBane R, Padmanabhan A. Risk of venous thromboembolism after COVID-19 vaccination. J Thromb Haemost. 2022 Jul; 20 (7):1638-1644 Epub 2022 Apr 20
   View PubMed
8. Hirao-Try Y, Vlazny DT, Meverden R, Houghton DE, Casanegra AI, Froehling DA, Hodge DO, Peterson LG, McBane RD, Wysokinski WE. Single versus multiple and incidental versus symptomatic subsegmental pulmonary embolism: clinical characteristics and outcome. J Thromb Thrombolysis. 2022 Jul; 54(1):82-90. Epub 2022 Jan 07.
   View PubMed
9. Quintero-Martinez JA, Wysokinski WE, Cordova-Madera SN, Mogollon RJ, Garcia-Arango M, Vlazny DT, Houghton DE, Casanegra AI, Villarraga HR. Pulmonary artery capacitance and pulmonary vascular resistance as prognostic indicators in acute pulmonary embolism. Eur Heart J Open. 2022 Mar; 2 (2):oeac007 Epub 2022 Feb 23
   View PubMed
10. Houghton DE, Vlazny DT, Casanegra AI, Brunton N, Froehling DA, Meverden RA, Hodge DO, Peterson LG, McBane RD, Wysokinski WE. Bleeding in Patients With Gastrointestinal Cancer Compared With Nongastrointestinal Cancer Treated With Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism. Mayo Clin Proc. 2021 Nov; 96(11):2793-2805. Epub 2021 Aug 20.
    View PubMed
11. Casanegra AI, Shepherd RF. Raynaud Phenomenon and Other Vasospastic Disorders. Cardiol Clin. 2021 Nov; 39 (4):583-599
    View PubMed
12. Gardner AW, Montgomery PS, Wang M, Shen B, Casanegra AI, Silva-Palacios F, Ungvari Z, Yabluchanskiy A, Csiszar A, Waldstein SR. Cognitive decrement in older adults with symptomatic peripheral artery disease. Geroscience. 2021 Oct; 43 (5):2455-2465 Epub 2021 Sept 09
    View PubMed
13. Henkin S, McBane RD 2nd, Rooke TW, Wysokinski WE, Casanegra AI, Liedl DA, Wennberg PW. Major adverse events associated with inducible cardiac ischemia during treadmill exercise testing for peripheral artery disease. J Vasc Surg. 2021 Oct; 74 (4):1335-1342.e2 Epub 2021 Apr 19
    View PubMed
14. Vlazny DT, Pasha AK, Kuczmik W, Wysokinski WE, Bartlett M, Houghton D, Casanegra AI, Daniels P, Froehling DA, White LJ, Hodge DO, McBane RD 2nd. Outcome of anticoagulation in isolated distal deep vein thrombosis compared to proximal deep venous thrombosis. J Thromb Haemost. 2021 Sep; 19 (9):2206-2215 Epub 2021 July 21
    View PubMed
15. Chaudhary R, Loganathan D, Vlazny DT, Casanegra AI, Houghton DE, Froehling DA, Peterson LG, Hodge DO, McBane RD 2nd, Wysokinski WE. Demographics and Clinical Outcomes in Patients Older Than 75 Years Treated for Acute Venous Thromboembolism. Am J Ther 2021 Jun 11; 29 (1):e151-e153 Epub 2021 June 11
    View PubMed
16. Brunton NE, Wysokinski WE, Hodge DO, Vlazny DT, Houghton DE, Casanegra AI. Delayed anticoagulation in venous thromboembolism: Reasons and associated outcomes. Res Pract Thromb Haemost. 2021 May; 5(4):e12500. Epub 2021 Apr 07.
    View PubMed
17. Kuczmik W, Wysokinski WE, Macedo T, Froehling D, Daniels P, Casanegra A, Houghton D, Vlazny D, Meverden R, Lang T, White L, Hodge D, McBane RD 2nd. Calf Vein Thrombosis Outcomes Comparing Anticoagulation and Serial Ultrasound Imaging Management Strategies. Mayo Clin Proc. 2021 May; 96 (5):1184-1192 Epub 2021 Apr 09
    View PubMed
18. Pasha AK, Kuczmik W, Wysokinski WE, Casanegra AI, Houghton D, Vlazny DT, Mertzig A, Hirao-Try Y, White L, Hodge D, McBane Ii R. Calf vein thrombosis outcomes comparing patients with and without cancer. J Thromb Thrombolysis. 2021 May; 51 (4):1059-1066 Epub 2021 Feb 04
    View PubMed
19. Gardner AW, Montgomery PS, Wang M, Shen B, Casanegra AI, Silva-Palacios F, Zhang S, Pomilla WA, Esponda OL, Kuroki M. Daily Step Counts in Participants With and Without Peripheral Artery Disease. J Cardiopulm Rehabil Prev. 2021 May 1; 41 (3):182-187
    View PubMed
20. Creager MA, Hamburg NM, Calligaro KD, Casanegra AI, Freeman R, Gordon PA, Gornik HL, Kim ESH, Leeper NJ, Merli GJ, Niazi K, Olin JW, Quiroz R, Rrapo Kaso E, Wasan S, Waxler AR, White CJ, White Solaru K, Williams MS, Writing Committee Members. 2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions): A Report of the ACC Competency Management Committee. J Am Coll Cardiol. 2021 Feb 23; 77 (7):998-1020 Epub 2020 Nov 26
    View PubMed
21. Creager MA, Hamburg NM, Calligaro KD, Casanegra AI, Freeman R, Gordon PA, Gornik HL, Kim ESH, Leeper NJ, Merli GJ, Niazi K, Olin JW, Quiroz R, Rrapo Kaso E, Wasan S, Waxler AR, White CJ, White Solaru K, Williams MS. 2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions). Circ Cardiovasc Interv. 2021 Feb; 14 (2):e000079 Epub 2021 Jan 15
    View PubMed
22. Creager MA, Hamburg NM, Calligaro KD, Casanegra AI, Freeman R, Gordon PA, Gornik HL, Kim ESH, Leeper NJ, Merli GJ, Niazi K, Olin JW, Quiroz R, Kaso ER, Wasan S, Waxler AR, White CJ, Solaru KW, Williams MS, Writing Committee Members. 2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions). Vasc Med. 2021 Feb; 26 (1):91-112 Epub 2021 Jan 15
    View PubMed
23. Kuczmik W, Wysokinski WE, Hesley GK, Vlazny DT, Houghton DE, Swanson KE, Casanegra AI, Hodge D, White L, McBane RD 2nd. Calf Vein Thrombosis Comparison of Outcomes for Axial and Muscular Venous Thrombosis. Thromb Haemost. 2021 Feb; 121 (2):216-223 Epub 2020 Aug 22
    View PubMed
24. Chaudhry AP, Hankey RA, Kaggal VC, Bhopalwala H, Liedl DA, Wennberg PW, Rooke TW, Scott CG, Disdier Moulder MP, Hendricks AK, Casanegra AI, McBane RD, Shellum JL, Kullo IJ, Nishimura RA, Chaudhry R, Arruda-Olson AM. Usability of a Digital Registry to Promote Secondary Prevention for Peripheral Artery Disease Patients. Mayo Clin Proc Innov Qual Outcomes. 2021 Feb; 5 (1):94-102 Epub 2020 Nov 28
    View PubMed
25. Zhang Y, Klarich KW, Cicek S, Maleszewski J, Casanegra AI. Recurrent Stroke in a 34-year-old: Unusual Presentation of Non-Bacterial Endocarditis Arch Clin Med Case Rep. 2020; 4(2):192-196.
26. McBane RD 2nd, Torres Roldan VD, Niven AS, Pruthi RK, Franco PM, Linderbaum JA, Casanegra AI, Oyen LJ, Houghton DE, Marshall AL, Ou NN, Siegel JL, Wysokinski WE, Padrnos LJ, Rivera CE, Flo GL, Shamoun FE, Silvers SM, Nayfeh T, Urtecho M, Shah S, Benkhadra R, Saadi SM, Firwana M, Jawaid T, Amin M, Prokop LJ, Murad MH. Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic. Mayo Clin Proc. 2020 Nov; 95 (11):2467-2486 Epub 2020 Aug 31
    View PubMed
27. Wysokinski WE, Froehling DA, Houghton DE, McBane RD, Vlazny DT, Bott-Kitslaar DM, Kuczmik W, Sutkowska K, Bator K, Hodge DO, Peterson LG, Casanegra AI. Effectiveness and safety of apixaban and rivaroxaban for acute venous thromboembolism therapy in patients with extremes in bodyweight. Eur J Haematol. 2020 Oct; 105 (4):484-494 Epub 2020 July 27
    View PubMed
28. Gardner AW, Montgomery PS, Wang M, Shen B, Casanegra AI, Silva-Palacios F, Knehans AW. Diet is associated with ankle-brachial index, inflammation, and ambulation in patients with intermittent claudication. J Vasc Surg. 2020 Oct; 72 (4):1375-1384 Epub 2020 Feb 28
    View PubMed
29. van Zyl M, Wysokinski WE, Jaeger TM, Casanegra AI, Gersh BJ, McBane RD 2nd. In-home Compared With In-Clinic Warfarin Therapy Monitoring in Mechanical Heart Valves: A Population-Based Study. Mayo Clin Proc Innov Qual Outcomes. 2020 Oct; 4 (5):511-520 Epub 2020 Aug 15
    View PubMed
30. Houghton DE, Casanegra AI, Peterson L, Cochuyt J, Hodge DO, Vlazny D, McBane RD, Froehling D, Wysokinski WE. Treatment of upper extremity deep vein thrombosis with apixaban and rivaroxaban. Am J Hematol. 2020 Jul; 95 (7):817-823 Epub 2020 Apr 20
    View PubMed
31. Cambron JC, Saba ES, McBane RD, Casanegra AI, Villarraga HR, Houghton DE, Vlazny DT, Froehling D, Hodge D, Peterson LG, Bott-Kitslaar DM, Wysokinski WE. Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary Embolism. Mayo Clin Proc Innov Qual Outcomes. 2020 Jun; 4 (3):249-258 Epub 2020 June 05
    View PubMed
32. Houghton DE, Lekah A, Macedo TA, Hodge D, Saadiq RA, Little Y, Casanegra AI, McBane RD, Wysokinski WE. Resolution of acute lower extremity deep vein thrombosis with rivaroxaban compared to warfarin. J Thromb Thrombolysis. 2020 Feb; 49 (2):199-205
    View PubMed
33. Cambron ,, Saba ,, McBane RD, Casanegra A, Villarraga HR, Houghton D, Vlazny DT, Froehling DA, Hodge DO, Peterson ,, Bott DM. Pulmonary embolism categories do not predict adverse events or mortality in anticoagulated patients CHEST. 2020.
34. Wysokinski WE, Houghton DE, Casanegra AI, Vlazny DT, Bott-Kitslaar DM, Froehling DA, Hodge DO, Peterson LG, Mcbane RD. Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer-associated venous thromboembolism. Am J Hematol. 2019 Nov; 94 (11):1185-1192 Epub 2019 Aug 19
    View PubMed
35. Bott-Kitslaar DM, McBane RD, Casanegra AI, Houghton DE, Froehling DA, Vlazny DT, Ashrani AA, Hodge DO, Vargas ER, Bartlett MA, Saadiq RA, Daniels PR, Shields RC, Lenz CJ, Lang TR, Wysokinski WE. Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism. Mayo Clin Proc. 2019 Jul; 94 (7):1242-1252 Epub 2019 Feb 06
    View PubMed
36. Simmons B, Wysokinski W, Saadiq RA, Bott-Kitslaar D, Henkin S, Casanegra A, Lenz C, Daniels P, Bjarnason H, Vargas E, Hodge D, Holton SJ, Cerhan JR, Loprinzi C, McBane R 2nd. Efficacy and safety of rivaroxaban compared to enoxaparin in treatment of cancer-associated venous thromboembolism. Eur J Haematol. 2018 Apr 4 Epub 2018 Apr 04
    View PubMed
37. Lenz CJ, McBane RD, Cohoon KP, Janczak DT, Simmons BS, Saadiq RA, Mimier M, Casanegra AI, Daniels PR, Wysokinski WE. Testicular vein thrombosis: Incidence of recurrent venous thromboembolism and survival. Eur J Haematol. 2018 Jan; 100 (1):83-87 Epub 2017 Nov 13
    View PubMed
38. Lenz CJ, Wysokinski WE, Henkin S, Cohoon KP, Casanegra A, Simmons BS, Saadiq RA, Daniels PR, Wysokinska EM, Bjarnason H, McBane RD. Ovarian Vein Thrombosis: Incidence of Recurrent Venous Thromboembolism and Survival. Obstet Gynecol. 2017 Nov; 130 (5):1127-1135
    View PubMed
39. Casanegra AI, McBane RD, Bjarnason H. Intervention radiology for venous thrombosis: early thrombus removal using invasive methods. Br J Haematol. 2017 Apr; 177 (2):173-184 Epub 2017 Apr 02
    View PubMed
40. Casanegra AI, Stoner JA, Tafur AJ, Pereira HA, Rathbun SW, Gardner AW. Differences in galectin-3, a biomarker of fibrosis, between participants with peripheral artery disease and participants with normal ankle-brachial index. Vasc Med. 2016 Oct; 21: (5)437-444.
    View PubMed
41. Iftikhar O, Oliveros K, Tafur AJ, Casanegra AI. Prevention of Femoropopliteal In-Stent Restenosis With Cilostazol: A Meta-Analysis. Angiology. 2016 Jul; 67: (6)549-55.
    View PubMed
42. Gardner AW, Montgomery PS, Casanegra AI, Silva-Palacios F, Ungvari Z, Csiszar A. Association between gait characteristics and endothelial oxidative stress and inflammation in patients with symptomatic peripheral artery disease. Age (Dordr). 2016 Jun; 38: (3)64.
    View PubMed
43. Farah BQ, Ritti-Dias RM, Montgomery PS, Casanegra AI, Silva-Palacios F, Gardner AW. Sedentary behavior is associated with impaired biomarkers in claudicants. J Vasc Surg. 2016 Mar; 63: (3)657-63.
    View PubMed
44. Casanegra AI, Landrum LM, Tafur AJ. Retrievable Inferior Vena Cava Filters in Patients with Cancer: Complications and Retrieval Success Rate. Int J Vasc Med. 2016; 2016:6413541.
    View PubMed
45. Gardner AW, Parker DE, Montgomery PS, Sosnowska D, Casanegra AI, Ungvari Z, Csiszar A, Zhang SX, Wang JJ, Sonntag WE. INFLUENCE OF DIABETES ON AMBULATION AND INFLAMMATION IN MEN AND WOMEN WITH SYMPTOMATIC PERIPHERAL ARTERY DISEASE. J Clin Transl Endocrinol. 2015 Dec 01; 2: (4)137-143.
    View PubMed
46. Silva-Palacios F, Casanegra AI, Shapiro A, Phan M, Hawkins B, Li J, Stoner J, Tafur A. Impact of tornadoes on hospital admissions for acute cardiovascular events. Thromb Res. 2015 Nov; 136: (5)907-10.
    View PubMed
47. Casanegra AI, Tafur AJ. Improved trainee experience with a structured subspecialty rotation. Med Educ. 2015 Nov; 49: (11)1148-9.
    View PubMed
48. Gardner AW, Parker DE, Montgomery PS, Sosnowska D, Casanegra AI, Ungvari Z, Csiszar A, Sonntag WE. Endothelial Cell Inflammation and Antioxidant Capacity are Associated With Exercise Performance and Microcirculation in Patients With Symptomatic Peripheral Artery Disease. Angiology. 2015 Oct; 66: (9)867-74.
    View PubMed
49. Salem G, Casanegra AI, Gierman JL, Hawkins BM, Tafur AJ. A young patient with concurrent splanchnic dynamic vascular compression syndromes. Vasc Med. 2015 Oct; 20: (5)489-90.
    View PubMed
50. Gardner AW, Parker DE, Montgomery PS, Sosnowska D, Casanegra AI, Ungvari Z, Csiszar A, Sonntag WE. Gender and racial differences in endothelial oxidative stress and inflammation in patients with symptomatic peripheral artery disease. J Vasc Surg. 2015 May; 61: (5)1249-57.
    View PubMed
51. Gardner AW, Parker DE, Montgomery PS, Sosnowska D, Casanegra AI, Esponda OL, Ungvari Z, Csiszar A, Sonntag WE. Impaired vascular endothelial growth factor A and inflammation in patients with peripheral artery disease. Angiology. 2014 Sep; 65: (8)683-90.
    View PubMed
52. Gardner AW, Parker DE, Montgomery PS, Blevins SM, Teague AM, Casanegra AI. Monitored daily ambulatory activity, inflammation, and oxidative stress in patients with claudication. Angiology. 2014 Jul; 65: (6)491-6.
    View PubMed
53. Joseph L, Casanegra AI, Dhariwal M, Smith MA, Raju MG, Militello MA, Gomes MP, Gornik HL, Bartholomew JR. Bivalirudin for the treatment of patients with confirmed or suspected heparin-induced thrombocytopenia. J Thromb Haemost. 2014 Jul; 12: (7)1044-53.
    View PubMed
54. Gardner AW, Parker DE, Montgomery PS, Sosnowska D, Casanegra AI, Ungvari Z, Csiszar A, Sonntag WE. Greater endothelial apoptosis and oxidative stress in patients with peripheral artery disease. Int J Vasc Med. 2014; 2014:160534.
    View PubMed
55. Phan M, John S, Casanegra AI, Rathbun S, Mansfield A, Stoner JA, Tafur AJ. Primary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysis. J Thromb Thrombolysis. 2014; 38: (2)241-9.
    View PubMed
56. Gardner AW, Alaupovic P, Parker DE, Montgomery PS, Roof A, Casanegra AI. Apolipoprotein profiles in subjects with and without peripheral artery disease. Vasc Med. 2013 Jun; 18: (3)129-35.
    View PubMed
57. Gardner AW, Alaupovic P, Parker DE, Montgomery PS, Esponda OL, Casanegra AI. Influence of peripheral artery disease and statin therapy on apolipoprotein profiles. Int J Vasc Med. 2013; 2013:548764.
    View PubMed
58. Casanegra AI, Whitelaw SM, Greenberg R, Kashyap V, Gornik H. Case series of subclavian artery aneurysms in the noninvasive vascular laboratory. JVU.2012;36:(1):1-7.
59. Casanegra AI, Brannan S, Dadu R, Ong P, Berner M, Spinning K, Hughes T, Marrinan G, Zinn K, Manthous C. Short-term femoral vein catheterization rarely causes thrombosis or bacteremia. J Hosp Med. 2011 Jan; 6: (1)33-6.
    View PubMed
60. Gheorghe C, Vazquez R, Casanegra AI, Argento V, Dadu R, Feng Y, Amoateng-Adjepong Y, Manthous CA. Elders' environs and their end-of-life preferences. J Am Med Dir Assoc. 2011 Jan; 12: (1)22-8.
    View PubMed
61. Jimenez PM, Conde C, Casanegra A, Romero C, Tabares AH, Orias M. Association of ACE genotype and predominantly diastolic hypertension: a preliminary study. J Renin Angiotensin Aldosterone Syst. 2007 Mar; 8: (1)42-4.
    View PubMed
62. Casanegra AI, Pereyra A, Casas JP, Robles AM, Lopez AM. Open lung biopsy in acutely ill patients Experiencia Medica.2001;19:19-22.